title: Which treatments had been tapered or stopped in rheumatoid arthritis in long-term DAS28 remission following subcutaneous tumor-necrosis-factor blocker therapy? A retrospective experience on 43 patients.
authors.forename: Sanae
authors.initials: S
authors.lastname: Ali Ou Alla
authors.forename: Cedric
authors.initials: C
authors.lastname: Lukas
authors.forename: Najia
authors.initials: N
authors.lastname: Hajjaj-Hassouni
authors.forename: René Marc
authors.initials: RM
authors.lastname: Flipo
authors.forename: Bernard
authors.initials: B
authors.lastname: Combe
authors.forename: Jacques
authors.initials: J
authors.lastname: Morel
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004185:Disability Evaluation; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012189:Retrospective Studies; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000305:Adrenal Cortex Hormones; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha